MichaelAndrewLobritzMDPhD
Infectious Disease • Boston, MAAttending Physician, Massachusetts General Hospital
Dr. Lobritz is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
55 Fruit St
Division Of Infectious Disease, Grj-504
Boston, MA 02114Phone+1 617-724-9248Fax+1 617-726-7653
Education & Training
Massachusetts General Hospital/Brigham and Women's Hospital/Harvard Medical SchoolFellowship, Infectious Disease, 2011 - 2013
Case Western Reserve University School of MedicineClass of 2009
Certifications & Licensure
MA State Medical License 2013 - 2017
CA State Medical License 2010 - 2011
Publications & Presentations
PubMed
- 22 citationsIncreased energy demand from anabolic-catabolic processes drives β-lactam antibiotic lethality.Michael A Lobritz, Ian W Andrews, Dana Braff, Caroline B M Porter, Arnaud Gutierrez
Cell Chemical Biology. 2022-02-17 - 1 citationsDeep Gene Sequence Cluster Analyses of Multi-Virus-Infected Mucosal Tissue Reveal Enhanced Transmission of Acute HIV-1.Katja Klein, Immaculate Nankya, Gabrielle Nickel, Annette N. Ratcliff, Adam Meadows
Journal of Virology. 2021-01-13 - 312 citationsBacterial Metabolism and Antibiotic EfficacyJonathan M. Stokes, Allison J. Lopatkin, Michael A. Lobritz, James J. Collins
Cell Metabolism. 2019-08-06
Press Mentions
New Antibiotic Uses Novel Method to Target Deadly Drug-Resistant Bacteria, Study SaysJanuary 10th, 2024- A Potent Antibiotic Has Emerged in the Battle Against Deadly, Drug-Resistant SuperbugsJanuary 10th, 2024
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
